Connection

Bryan Love to Drug Approval

This is a "connection" page, showing publications Bryan Love has written about Drug Approval.
Connection Strength

0.183
  1. Regulatory and clinical considerations for biosimilar oncology drugs. Lancet Oncol. 2014 Dec; 15(13):e594-e605.
    View in: PubMed
    Score: 0.119
  2. Therapeutic Advances in HCV Genotype 1 Infection: Insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy. 2016 Feb; 36(2):203-17.
    View in: PubMed
    Score: 0.032
  3. The changing landscape of adverse drug events associated with chronic hepatitis C virus therapy. Expert Opin Drug Saf. 2015; 14(11):1649-52.
    View in: PubMed
    Score: 0.031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.